Evidence map›Paper›PMID 25961064›Full record

ArticleJournal of immunology research2015

Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.

Brian J Franz, Ying Li, Constantine Bitsaktsis, Bibiana V Iglesias, Giang Pham, Raju Sunagar, Sudeep Kumar, Edmund J Gosselin

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Brian J FranzCenter for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Ying LiRegeneron Pharmaceuticals, 81 Columbia Turnpike, Rensselaer, NY 12144, USA.
Constantine BitsaktsisDepartment of Biological Sciences, Seton Hall University, South Orange, NJ 07079, USA.
Bibiana V IglesiasRegeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Giang PhamPfizer, 610 Main Street, Cambridge, MA 02139, USA.
Raju SunagarCenter for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Sudeep KumarCenter for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Edmund J GosselinCenter for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Albany Medical Center Hospital · USRegeneron (United States) · USPfizer (United States) · USSeton Hall University · US

Funding

TLR2/NLR Signal Regulation of Protective Immunity to F. TularensisP01AI056320 · NIAID · ALBANY MEDICAL COLLEGE · PI METZGER, DENNIS W · 2003 to 2016
$22.9M
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-TargetingR01AI100138 · NIAID · ALBANY MEDICAL COLLEGE · PI GOSSELIN, EDMUND J, HAZLETT, KARSTEN R.O. · 2013 to 2017
$2.9M
Mechanisms Involved in, and Development of, FcR-Enhanced Mucosal VaccinationR01AI076408 · NIAID · ALBANY MEDICAL COLLEGE · PI GOSSELIN, EDMUND J · 2009 to 2012
$1.5M
NIAID NIH HHS P01 AI056320NIAID NIH HHS P01AI056320NIAID NIH HHS R01 AI076408NIAID NIH HHS R01AI076408NIAID NIH HHS R01 AI100138NIAID NIH HHS R01AI100138
6 · The paper itself

Abstract

Fc gamma receptor IIB (FcγRIIB) is the only Fc gamma receptor (FcγR) which negatively regulates the immune response, when engaged by antigen- (Ag-) antibody (Ab) complexes. Thus, the generation of Ag-specific IgG in response to infection or immunization has the potential to downmodulate immune protection against infection. Therefore, we sought to determine the impact of FcγRIIB on immune protection against Francisella tularensis (Ft), a Category A biothreat agent. We utilized inactivated Ft (iFt) as an immunogen. Naïve and iFt-immunized FcγRIIB knockout (KO) or wildtype (WT) mice were challenged with Ft-live vaccine strain (LVS). While no significant difference in survival between naïve FcγRIIB KO versus WT mice was observed, iFt-immunized FcγRIIB KO mice were significantly better protected than iFt-immunized WT mice. Ft-specific IgA in serum and bronchial alveolar lavage, as well as IFN-γ, IL-10, and TNF-α production by splenocytes harvested from iFt-immunized FcγRIIB KO, were also significantly elevated. In addition, iFt-immunized FcγRIIB KO mice exhibited a reduction in proinflammatory cytokine levels in vivo at 5 days after challenge, which correlates with increased survival following Ft-LVS challenge in published studies. Thus, these studies demonstrate for the first time the ability of FcγRIIB to regulate vaccine-induced IgA production and downmodulate immunity and protection. The immune mechanisms behind the above observations and their potential impact on vaccine development are discussed.

Indexed as

Adoptive TransferAnimalsAntibodies, BacterialBacterial VaccinesBronchoalveolar Lavage FluidCytokinesFrancisella tularensisImmunoglobulin AImmunoglobulin GInterferon-gammaInterleukin-10Interleukin-17LungMiceMice, Inbred C57BLMice, KnockoutAntibodies, BacterialBacterial VaccinesCytokinesFcgr2b protein, mouseIL10 protein, humanIl17a protein, mouseImmunoglobulin AImmunoglobulin GInterferon-gammaInterleukin-10Interleukin-17Receptors, IgGTumor Necrosis Factor-alphaVaccines, Attenuated

Identifiers

PMID25961064
PMCPMC4417568
OpenAlexW2061982672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.